財務情報
- Market Capitalization 50.55 M
- Employee 17
- Founded 2009
- CEO N/A
- Website www.renovorx.com
- Headquarter Delaware, United States
- FIGI BBG005XWWZK6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.63
売上高対価格比率
26.43
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4140 | HYPD Hyperion DeFi, Inc. - Common Stock | 3.10 USD | -7.74% | -15.07% | -12.92% | -61.25% | 48.17 M USD | ||
| 4141 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | -0.77% | 0.00% | +0.56% | +1085.53% | 52.10 M USD | ||
| 4146 | ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.20 USD | +12.28% | -6.16% | -16.23% | -34.96% | 58.00 M USD | ||
| 4150 | MREO Mereo BioPharma Group plc - American Depositary Shares | 0.31 USD | -3.13% | -16.22% | +10.71% | -84.34% | 49.50 M USD |